LOUISVILLE, KY., March 2, 2016 -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that is has signed an agreement with Marshfield Clinic and facilitate easy integration of opiate prescription histories into electronic medical records (EMRs). The Appriss integration solution provides opiate prescription histories in real-time, at the point-of-care. This increased accessibility is expected to increase prescription monitoring data usage to improve patient safety and combat prescription drug abuse and diversion.
The Appriss secure integration technology provides a variety of options for health IT systems to integrate Prescription Monitoring Program (PMP) data into physician and pharmacist workflows. Physicians and pharmacists currently log into separate websites to retrieve a patient's opiate prescriptions and then cross-reference this data with a patient's health information in other systems. At Marshfield Clinic, the Appriss integration provides instant access to the patient's data within the electronic health records.
"Our Marshfield Clinic physicians have overwhelmingly embraced Appriss' mission of improving prescribing confidence," said Dr. Eric Penniman, East District 4 Medical Director for Primary Care. "Having access to prescription monitoring data directly from within the medication prescribing program has been significant for our physicians and they are universally grateful for this EMR tool."
The benefits of EHR integration and interoperability have long been recognized by Brandeis University's PDMP Center of Excellence (COE). The September 2012 Guidance of PDMP Best Practices recognizes that "integrating PDMP data retrieval with health information exchanges (HIE), electronic health records (EHR), and pharmacy dispensing systems should help reduce the time and effort needed for prescribers and their staff and for pharmacists to access a patient's prescription history." (http://www.pdmpexcellence.org/). The report further details that integration will maximize both the number of users (prescribers and dispensers) receiving the information and the utility for each of those users.
"By providing prescription monitoring data directly at the point-of-care, Marshfield has taken a major step towards improving patient safety in Wisconsin," said Ken Cassell, Vice President of Business Development at Appriss. "Real-time monitoring also saves valuable minutes for providers, helping to ensure the best standard of care for all patients."
For more information about Appriss integration technologies, please visit http://www.appriss.com/pmpgateway.html and http://www.appriss.com/narxcheck.html.
About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.
For more information, visit www.appriss.com (http://www.appriss.com).
CONTACT: Kathy Sue Bennett
Marketing Manager
Appriss, Inc.
[email protected]


FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 



